RxDoctor Payments Data

Michael Johnson, MD

Orthopaedic Surgery · Oklahoma City, OKNPI 1871753939

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (58.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 97.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $25,827 and has fallen 58.9% since, to $10,613 in 2025. Among orthopaedic surgery clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$63,427in general payments, 2019–2025

Across 118 payments — averaging $537.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$62K
  • Arthrex$1K
  • Pylant Medical$39
  • Amgen$24
  • Organogenesis Inc.$23
$69,547in research payments, 2019–2025

Across 17 payments — averaging $4090.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$70K

What the payments were for

  • Consulting fees$12,71920%
  • Speaking & faculty fees$36,77658%
  • Travel & lodging$9,84116%
  • Food & beverage$2,7724%
  • Education$1,3192%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew111$62,006
Arthrex2$1,335
Pylant Medical2$39
Amgen2$24
Organogenesis Inc.1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$63,427 in reported general payments places this provider in the 90th percentile of 263 orthopaedic surgery providers in Oklahoma.

See all orthopaedic surgery providers in Oklahoma

Medicare billing

Part B allowed, 2024
$76,134
Medicare patients
152
Services billed
382

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen46$792

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →